Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...

TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...

Here’s how to get relief from the nausea, anxiety, pain, and other symptoms of advanced prostate cancer and its treatments. Palliative care can make life more manageable during cancer treatment, but ...

For years, Laurel, Maryland, resident Michael Cominski coped with the effects of an enlarged prostate. He woke up as many as five times a night to use the bathroom, and it began to take a toll.

ProstAfense outlines how its circulation-driven prostate formula is positioned as the strongest, fast-acting option for men over 40 in 2026 - including saw palmetto and plant sterol research context, ...

In this context, "claims evaluated" refers to how ProstAfense presents and explains its own formulation approach and ingredient structure, rather than a comparative or third-party product review.